William Gross - Jun 22, 2023 Form 4 Insider Report for Heliogen, Inc. (HLGN)

Role
10%+ Owner
Signature
/s/ William Gross
Stock symbol
HLGN
Transactions as of
Jun 22, 2023
Transactions value $
-$13,448
Form type
4
Date filed
6/23/2023, 06:33 PM
Previous filing
Jun 16, 2023
Next filing
Dec 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLGN Common Stock Options Exercise $155K +858K +19.35% $0.18 5.29M Jun 22, 2023 Direct
transaction HLGN Common Stock Sale -$168K -730K -13.79% $0.23 4.56M Jun 22, 2023 Direct F1
holding HLGN Common Stock 414K Jun 22, 2023 See footnote F2
holding HLGN Common Stock 16.2K Jun 22, 2023 See footnote F3
holding HLGN Common Stock 15.5M Jun 22, 2023 See footnote F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLGN Employee Stock Option (right to buy) Options Exercise $0 -858K -100% $0.00* 0 Jun 22, 2023 Common Stock 858K $0.18 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.23 to $0.24, inclusive. Mr. Gross undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold each separate price within the ranges set forth in footnote (1) to this Form 4.
F2 These shares are held by The Gross Goodstein Living Trust (the "Trust") of which Mr. Gross is a co-trustee. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F3 These shares are held by Idealab Studio, LLC ("Idealab Studio"), for which Mr. Gross serves as chairman and chief executive officer. The Trust owns a majority of the class of securities of Idealab Studio entitled to elect two managers to Idealab Studio's board of managers. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F4 These shares are held by Idealab Holdings, LLC ("Idealab Holdings"), which is a wholly owned subsidiary of Idealab, a California corporation ("Idealab"). Idealab is managed by a board of directors (the "Idealab Board") including Mr. Gross. Mr. Gross may be deemed to beneficially own these shares. Mr. Gross disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F5 The options vested and became exercisable in equal monthly installments commencing December 21, 2020, subject to Mr. Gross's continuous service which ceased effective February 5, 2023.
F6 The options were exercisable through the indicated expiration date pursuant to an extension granted by the Issuer. The original expiration date was approximately 10 years from the initial vesting date of options with the same exercise price.